Table 5.
Factors associated with conduit reintervention (n=61)
Variable | Univariable analysis | Multivariable analysis | |||
---|---|---|---|---|---|
|
|
||||
HR (95% CI) | p-value | HR (95% CI) | p-value | ||
Age at operation (mo) | 0.87 (0.81–0.93) | <0.001 | 0.92 (0.82–1.03) | 0.175 | |
Weight at operation (kg) | 0.76 (0.67–0.87) | <0.001 | |||
Prematurity | 0.63 (0.28–1.38) | 0.252 | |||
Previous palliative cardiac surgery | 0.30 (0.18–0.52) | 0.001 | 0.44 (0.18–1.06) | 0.068 | |
Chromosomal abnormality | 0.71 (0.36–1.42) | 0.341 | |||
Conduit diameter, z-score | 0.59 (0.42–0.84) | 0.003 | 0.57 (0.40–0.83) | 0.003 | |
Concomitant pulmonary arterioplasty | 0.73 (0.42–1.25) | 0.253 | |||
Type of conduit | 0.78 (0.61–0.98) | 0.038 | 1.05 (0.82–1.03) | 0.742 | |
Contegra conduit | Reference | ||||
Valved PTFE conduit | 2.33 (1.28–4.24) | 0.005 | |||
Valveless PTFE | 2.43 (1.13–5.19) | 0.021 | |||
Hancock valved conduit | 1.10 (0.37–3.30) | 0.857 | |||
Primary cardiac diagnosis | 1.21 (0.93–1.34) | 0.225 | |||
Cardiopulmonary bypass time | 1.00 (0.99–1.00) | 0.330 | |||
Aortic cross-clamp time | 1.00 (0.99–1.01) | 0.308 |
HR, hazard ratio; CI, confidence interval; PTFE, polytetrafluoroethylene.